Hemp

• Indication: Temporarily relieves pain associated with arthritis, joint pain and muscle cramps

Directions For Use: Liberally apply lotion to affected area and rub into joints. Use 3-4 times per day for the first week. Use as needed thereafter to relieve discomfort. Use no more than 4 times per day. Allow several days for product to take maximum effect. Use within 60 days from opening. Store at 50° to 75°F (10°C to 24°C)

• For external use only . Not for use on open wounds. • If symptoms persist or worsen, discontinue use, seek medical attention. • Avoid contact with eyes. If product gets into eyes, flush with water, seek medical attention. • If rash, redness, irritation or itching occurs, discontinue use. • If pregnant or breastfeeding ask a health professional before use. • If swallowed, get medical help or contact a Poison Center. • Keep out of reach of children.

1. 1Application Site Pain323%
2. 2Drug Hypersensitivity215%
3. 3Off Label Use215%
4. 4Overdose215%
5. 5Abortion Induced17.7%
6. 6Anxiety17.7%
7. 7Application Site Erythema17.7%
8. 8Application Site Irritation17.7%
9. 9Application Site Rash17.7%
10. 10Cardiac Arrest17.7%
11. 11Continuous Positive Airway Pressure17.7%
12. 12Cough17.7%
13. 13Drug Ineffective For Unapproved Indication17.7%
14. 14Drug Interaction17.7%
15. 15Drug Level Increased17.7%

Recent PubMed references pinned to Hemp as a MeSH major topic. Citations link to pubmed.ncbi.nlm.nih.gov.

• Chemical Characterization and Biological Potential of the Essential Oils from the Flowers of Two Cannabis sativa L. Cultivars from Komga, South Africa.
  Molecules (Basel, Switzerland) · 2026 · Odieka AE, Oriola AO, Miya GM, et al.
  PMID 42280118DOI 10.3390/molecules31111814
• Genome-wide characterization of MADS-box genes reveals CsaSOC1 as a key regulator of flowering in Cannabis sativa L.
  Plant cell reports · 2026 · Li S, Zhao Q, Wang F, et al.
  PMID 42262439DOI 10.1007/s00299-026-03871-0
• Improvement of cannabichromenic acid synthase activity and construction of recombinant yeast strain.
  Archives of microbiology · 2026 · Wang L, Chi J, Jiang D, et al.
  PMID 42250120DOI 10.1007/s00203-026-04976-6
• Oromucosal Administration of a Cannabidiol-Enriched Cannabis sp. Extract for 2 Weeks Moderately Reduces Cold Hyperalgesia in Rats With Neuropathic Pain.
  European journal of pain (London, England) · 2026 · Campos RMP, Conde L, Aguiar A, et al.
  PMID 42248695DOI 10.1002/ejp.70307
• [Regulated cannabis distribution pilot studies in Switzerland: an example in Geneva].
  Revue medicale suisse · 2026 · Cina N, Dreifuss Bisson M, Zullino D, et al.
  PMID 42237640DOI 10.53738/REVMED.2026.22.965.48650
• Structural characterization and in vitro evaluation of the hypolipidemic activity of the HSP-Ia, a bioactive polysaccharide derived from hemp (Cannabis sativa L.) seeds.
  Carbohydrate polymers · 2026 · Wang YZ, Li LY, Chen YZ, et al.
  PMID 42230038DOI 10.1016/j.carbpol.2026.125439
• Surveillance of Cannabis Strains Using Online Data: Observational Study.
  JMIR formative research · 2026 · Yoon DW, Qiu Z, Park H, et al.
  PMID 42228913DOI 10.2196/89897
• Local availability of cannabis retail outlets on parents' cannabis use, acceptability, and perceived addictiveness: A longitudinal study in Washington State.
  PloS one · 2026 · Le VT, Bailey JA, Epstein M, et al.
  PMID 42201904DOI 10.1371/journal.pone.0348182

The 10 most recently updated of 116 ClinicalTrials.gov registrations naming Hemp as an intervention. Registration is not evidence of efficacy or safety — reference crosswalk only.

• Longitudinal Outpatient Treatment for Cannabis Use Disorder
  Recruiting · Phase 2 · Interventional · 165 enrolled · University of Colorado, Boulder
  NCT06107062updated 2026-06-12
• Human Experimental Models of Pain (HEMP)
  Not yet recruiting · Interventional · 25 enrolled · National Center for Complementary and Integrative Health (NCCIH)
  NCT07549490updated 2026-06-12
• Mechanisms of Cannabidiol and Sleep in the Context of Alcohol Use
  Not yet recruiting · Phase 2 · Interventional · 58 enrolled · University of Colorado, Boulder
  NCT07527338updated 2026-06-11
• Cannabidiol and Older Adult Cannabis Users
  Recruiting · Phase 2 · Interventional · 385 enrolled · University of Colorado, Boulder
  NCT06290063updated 2026-06-10
• Effects of a Hemp Product on the Pharmacokinetics and Pharmacodynamics of Clopidogrel
  Recruiting · Early phase 1 · Interventional · 24 enrolled · Washington State University
  NCT06692933updated 2026-06-04
• Impact of Cannabinoids on Menopause Symptoms
  Completed · Phase 2 · Interventional · 104 enrolled · Washington State University
  NCT06831916updated 2026-06-02
• A Study of Herbal Supplements in Cancer Survivors With Constipation
  Recruiting · Interventional · 70 enrolled · Memorial Sloan Kettering Cancer Center
  NCT07091084updated 2026-05-22
• The Pharmacokinetics of a Hemp-Based Topical Product
  Not yet recruiting · Phase 1 · Interventional · 20 enrolled · Johns Hopkins University
  NCT07603518updated 2026-05-22
• Clinical Trial on Agitation in Alzheimer's Dementia
  Recruiting · Phase 2 · Interventional · 164 enrolled · IGC Pharma, LLC
  NCT05543681updated 2026-05-20
• Safety Evaluation of THC-Free Hemp Protein Isolate
  Completed · Interventional · 32 enrolled · National University of Natural Medicine
  NCT07022275updated 2026-05-12

Frequently asked questions

What is Hemp used for?

According to FDA labeling, Hemp carries indications including: Indication: Temporarily relieves pain associated with arthritis, joint pain and muscle cramps. This is a reference summary of labeled uses, not medical advice or a treatment recommendation.